Literature DB >> 10394106

Cord-blood-derived human cultured mast cells produce interleukin 13 in the presence of stem cell factor.

N Kanbe1, M Kurosawa, T Yamashita, F Kurimoto, Y Yanagihara, Y Miyachi.   

Abstract

BACKGROUND: Mast cells have been regarded as a potential source of cytokines. Although the human mast cell line HMC-1 and human lung mast cells have been shown to produce interleukin (IL) 13, it still remains uncertain whether cord-blood-derived human cultured mast cells produce IL-13.
METHODS: Human cultured mast cells were raised from cord blood cells in the presence of stem cell factor (SCF) and IL-6. Levels of IL-13 mRNA were examined by a semiquantitative reverse transcriptase-polymerase chain reaction. IL-13 levels in the supernatants were measured with an enzyme-linked immunosorbent assay.
RESULTS: When the IgE-sensitized cultured mast cells were activated with anti-IgE, mRNA for IL-13 was amplified with a peak at 3 h after the stimulation. IL-13 was not detected in the supernatants of the activated mast cells in the absence of SCF, whereas the mast cells secreted significant amounts of IL-13 after the stimulation in the presence of SCF. Calcium ionophore A23187 also stimulated the mast cells to release IL-13 into the supernatant in the presence of SCF.
CONCLUSIONS: These observations suggest that human mast cells can produce IL-13 under the condition with SCF. The cord-blood-derived human cultured mast cells will help in studying the functional properties of human mast cells in allergic diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394106     DOI: 10.1159/000024189

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  3 in total

1.  Interaction between prostaglandin D and chemoattractant receptor-homologous molecule expressed on Th2 cells mediates cytokine production by Th2 lymphocytes in response to activated mast cells.

Authors:  L Xue; A Barrow; R Pettipher
Journal:  Clin Exp Immunol       Date:  2009-02-11       Impact factor: 4.330

2.  Inflammasome components ASC and AIM2 modulate the acute phase of biomaterial implant-induced foreign body responses.

Authors:  Susan N Christo; Kerrilyn R Diener; Jim Manavis; Michele A Grimbaldeston; Akash Bachhuka; Krasimir Vasilev; John D Hayball
Journal:  Sci Rep       Date:  2016-02-10       Impact factor: 4.379

Review 3.  Innate Immunity and Biomaterials at the Nexus: Friends or Foes.

Authors:  Susan N Christo; Kerrilyn R Diener; Akash Bachhuka; Krasimir Vasilev; John D Hayball
Journal:  Biomed Res Int       Date:  2015-07-12       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.